Bastiaan Sallevelt

258 CHAPTER 3.2 Table SI1.1. Baseline medications grouped by ATC drug class and study group. ATC code ATC group name Intervention group N (%) Control group N (%) B01 Antithrombotic agents 862 (8.6) 971 (9.3) C03 Diuretics 644 (6.5) 685 (6.5) A02 Drugs for acid related disorders 631 (6.3) 656 (6.3) C10 Lipid modifying agents 570 (5.7) 651 (6.2) R03 Adrenergics, inhalants 613 (6.1) 586 (5.6) C09 Agents acting on the reninangiotensin system 559 (5.6) 618 (5.9) C07 Beta blocking agents 537 (5.4) 576 (5.5) N02 Analgesics 547 (5.5) 526 (5.0) A11 Vitamins 516 (5.2) 472 (4.5) A10 Drugs used in diabetes 434 (4.4) 531 (5.1) N05 Psychotropics 344 (3.5) 368 (3.5) A12 Mineral supplements 344 (3.5) 339 (3.2) N06 Psychoanaleptics 301 (3.0) 321 (3.1) C08 Calcium channel blockers 276 (2.8) 287 (2.7) G04 Urologicals 230 (2.3) 306 (2.9) A06 Drugs for constipation 251 (2.5) 262 (2.5) C01 Cardiac therapy 242 (2.4) 232 (2.2) S01 Ophthalmologicals 202 (2.0) 179 (1.7) B03 Antianemic preparations 170 (1.7) 205 (2.0) N03 Antiepileptics 137 (1.4) 195 (1.9) H03 Thyroid therapy 157 (1.6) 145 (1.4) H02 Corticosteroids for systemic use 139 (1.4) 127 (1.2) M04 Antigout preparations 110 (1.1) 156 (1.5) Total 9,970 10,479 Note: Drug classes with <1% prevalence were omitted from this table for readability.

RkJQdWJsaXNoZXIy MTk4NDMw